Vicks took the top spot ahead of Rinvoq, Skyrizi and Tremfya, which continue to be the top spenders on national TV pharma ads.

Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive ...

The free-for-all-era of weight-loss copycats is ending, but will likely morph into something else.

As more states enact laws that regulate how AI is used in healthcare marketing, pharma marketers will need to build guardrails around transparency, bias and human-in-the-loop.

As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

The new year is shaping up to be a defining year following a dramatic 2025, and one where the impact from last year's developments will crystallize.

And there's more than one way to monetize this technology.

Study to be conducted by PharmaLegacy, a leading Contract Research Organization The scientific rationale for evaluating ...

Delve into the strategic alliance behind TrumpRx. We analyze why Big Pharma is partnering with Trump and what it means for insurance, patients, and the future of medicine.

Two weeks after launch, 91% of people had confirmed that they had completed the training. That level of visibility ...

While AI has already made inroads into drug discovery and clinical research, its most profound impact may be in quality ...